None listed
Conditions
Brief summary
The initial pilot study for this trial was registered with ANZCTR (ACTRN12610000532000) and completed in July 2010. The purpose of this study is to ascertain whether oral garlic tablets reduce vaginal colonisation of Candida (the yeast that causes thrush) when taken in the second half of the menstrual cycle, in women of childbearing age. Women will be asked to take three garlic tablets (or placebo) for two weeks, as well as send daily vaginal swabs to the laboratory for analysis, and complete a daily diary. This will give information not yet known about colonisation patterns of Candida in the second half of the menstrual cycle, as well as whether or not oral garlic tablets may be helpful in reducing recurrences of episodes of vaginal thrush.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
18-50 years, of reproductive age Previous history of vulvovaginal candidiasis (VVC) Asymptomatic for vaginitis (i.e. no abnormal vaginal discharge or itchiness) Able to take two vaginal swabs and post them daily for approximately 14 days Able and willing to take 2 herbal tablets twice a day for approximately 14 days Agree not to self medicate with over the counter medications, herbal or complementary medicines, and abstain from added garlic in diet for the duration of the study
Exclusion criteria
Allergy to garlic Bleeding disorders / taking warfarin / peptic ulcers Intended surgery during or immediately after the study period Pregnant or breastfeeding